Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CDKN2B deletion
i
Other names:
CDKN2B, Cyclin Dependent Kinase Inhibitor 2B, Cyclin-Dependent Kinase Inhibitor 2B (P15, Inhibits CDK4), Cyclin-Dependent Kinase 4 Inhibitor B, Multiple Tumor Suppressor, P14-INK4b, P15-INK4b, MTS-2, MTS2, Cyclin-Dependent Kinases 4 And 6 Binding Protein, CDK Inhibitory Protein, P14_CDK Inhibitor, P15 CDK Inhibitor, CDK4B Inhibitor, P14_INK4B, P15_INK4B, P15INK4b, P15INK4B, CDK4I, INK4B, TP15, P15
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
1030
Related biomarkers:
Expression
Mutation
CNA
Others
‹
IKZF1 deletion + CDKN2B deletion (2)
MTAP deletion + CDKN2A deletion + CDKN2B deletion + BAP1 deletion (1)
IKZF1 deletion + CDKN2A deletion + CDKN2B deletion + PAX5 deletion (0)
IKZF1 deletion + CDKN2B deletion (2)
MTAP deletion + CDKN2A deletion + CDKN2B deletion + BAP1 deletion (1)
IKZF1 deletion + CDKN2A deletion + CDKN2B deletion + PAX5 deletion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CDKN2B deletion
Gastric Adenocarcinoma
CDKN2B deletion
Gastric Adenocarcinoma
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
Immunotherapy
Resistant: C3 – Early Trials
Immunotherapy
Resistant
:
C3
CDKN2B deletion
Diffuse Large B Cell Lymphoma
CDKN2B deletion
Diffuse Large B Cell Lymphoma
T-lymphocyte cell therapy
Resistant: C3 – Early Trials
T-lymphocyte cell therapy
Resistant
:
C3
T-lymphocyte cell therapy
Resistant: C3 – Early Trials
T-lymphocyte cell therapy
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login